HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Imaging the evolution of reactivation pulmonary tuberculosis in mice using 18F-FDG PET.

AbstractUNLABELLED:
Latent tuberculosis infection affects one third of the world's population and can reactivate (relapse) decades later. However, current technologies, dependent on postmortem analyses, cannot follow the temporal evolution of disease.
METHODS:
C3HeB/FeJ mice, which develop necrotic and hypoxic tuberculosis lesions, were aerosol-infected with Mycobacterium tuberculosis. PET and CT were used to serially image the same cohort of infected mice through pretreatment, tuberculosis treatment, and subsequent development of relapse.
RESULTS:
A novel diffeomorphic registration was successfully used to monitor the spatial evolution of individual pulmonary lesions. Although most lesions during relapse developed in the same regions as those noted during pretreatment, several lesions also arose de novo within regions with no prior lesions.
CONCLUSION:
This study presents a novel model that simulates infection and reactivation disease as seen in humans and could prove valuable to study tuberculosis pathogenesis and evaluate novel therapeutics.
AuthorsAllison M Murawski, Saumya Gurbani, Jamie S Harper, Mariah Klunk, Laurent Younes, Sanjay K Jain, Bruno M Jedynak
JournalJournal of nuclear medicine : official publication, Society of Nuclear Medicine (J Nucl Med) Vol. 55 Issue 10 Pg. 1726-9 (Oct 2014) ISSN: 1535-5667 [Electronic] United States
PMID25082854 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Chemical References
  • Antitubercular Agents
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
Topics
  • Animals
  • Antitubercular Agents (pharmacology)
  • Disease Models, Animal
  • Female
  • Fluorodeoxyglucose F18
  • Lung (diagnostic imaging)
  • Mice
  • Mice, Inbred C3H
  • Mycobacterium tuberculosis
  • Positron-Emission Tomography (methods)
  • Radiopharmaceuticals (pharmacology)
  • Recurrence
  • Tomography, X-Ray Computed (methods)
  • Tuberculosis, Pulmonary (diagnostic imaging)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: